What is Nuvation Bio's stock-based comp?

Nuvation Bio (NUVB) reported stock-based comp of $9.03M in Q1 2026.

How has Nuvation Bio's stock-based comp changed year-over-year?

Nuvation Bio's stock-based comp increased by 15.0% year-over-year, from $7.85M to $9.03M.

What is the long-term trend for Nuvation Bio's stock-based comp?

Over 4 years (2021 to 2025), Nuvation Bio's stock-based comp has grown at a 40.3% compound annual growth rate (CAGR), from $9.27M to $35.89M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Nuvation Bio NUVB Stock-Based Comp

Stock-Based Comp at other companies

Bristol-Myers SquibbBMY

$146M+1.4%

PfizerPFE

$272M+60.0%

Nuvalent, Inc.NUVL

$28.88M+41.7%

ImmunomeIMNM

$7.95M+39.5%

ArriVent BioPharma, Inc.AVBP

$5.49M+142%

Arcus BiosciencesRCUS

$19M+18.8%

Other financials

Income statement

See full

Revenue$83.2M+2,599%

Gross profit$9.8M+1,340%

Operating income$3.9M+107%

Net income$5.4M+110%

EPS (diluted)$0.01+106%

Balance sheet

See full

Cash & equivalents$125.4M+161%

Total debt$57.2M+401%

Total equity$319.6M-23.8%

Total assets$610.2M+23.9%

Cash flow

See full

Operating cash flow$5.1M+112%

CapEx$48.0K-33.3%

Free cash flow$5.0M+112%

Valuation

See full

Market cap$2.1B+150%

Enterprise value$2.03B+154%

P/S14.7×-62.0×

Profitability

See full

Gross margin54.3%+39.5pp

Operating margin-105%-52.0pp

Net margin-102.1%-50.6pp

FCF margin-93.5%-45.2pp

Returns & leverage

See full

Return on equity-39.5%-15.8pp

Debt / equity0.2×+0.2×

Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nuvation Bio's stock-based comp?: Nuvation Bio (NUVB) reported stock-based comp of $9.03M in Q1 2026.
How has Nuvation Bio's stock-based comp changed year-over-year?: Nuvation Bio's stock-based comp increased by 15.0% year-over-year, from $7.85M to $9.03M.
What is the long-term trend for Nuvation Bio's stock-based comp?: Over 4 years (2021 to 2025), Nuvation Bio's stock-based comp has grown at a 40.3% compound annual growth rate (CAGR), from $9.27M to $35.89M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.